Patents/Assignees

Eisai R&D Management Co., Ltd.

52 patents in portfolio

US12220398utility2025
Tumor Therapeutic Agent
0 cites
US12214050utility2025
C-terminal Lysine Conjugated Immunoglobulins
0 cites
US12172986utility2024
Splicing Modulator Antibody-drug Conjugates and Methods of Use
0 cites
US12168014utility2024
Method for Treating Cancer
0 cites
US12042560utility2024
Liposome Composition
0 cites
US12043670utility2024
Anti-bcma Antibody-drug Conjugates and Methods of Use
0 cites
US12029724utility2024
Method for Inhibiting Tumor Growth
0 cites
USD1032850design2024
Health Condition Monitoring Set
0 cites
US11998544utility2024
Methods of Using Splicing Modulators
0 cites
US11945807utility2024
Splicing Modulator Antibody-drug Conjugates and Methods of Use
0 cites
US11925639utility2024
Tumor-treating Pharmaceutical Composition
0 cites
US11926619utility2024
Certain Pladienolide Compounds and Methods of Use
0 cites
US11833119utility2023
Combination Therapies for the Treatment of Hepatocellular Carcinoma
0 cites
US11833146utility2023
Dementia Therapeutic Agent Combining Pyrazoloquinoline Derivative and Donepezil
0 cites
US11814398utility2023
Macrocyclic Compounds and Uses Thereof
0 cites
US11761045utility2023
Splice Variants Associated with Neomorphic SF3B1 Mutants
0 cites
US11753669utility2023
Lysine Conjugated Immunoglobulins
0 cites
US11725015utility2023
Macrocyclic Compound and Uses Thereof
0 cites
US11707448utility2023
Combination Therapies for the Treatment of Cancer
0 cites
US11691990utility2023
Salts of Compounds and Crystals Thereof
0 cites

← PreviousPage 2 of 3Next →